ARCHIVES

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

Public Meeting On Ionizing Radiation Set

January 11, 1980

NCAB ‘Incredulous’ Over Proposed Ethics Rules, Bard Members Threaten Resignation In Letter

October 4, 1991

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

Avon Awards $16.2 Million To Cancer Centers, Others.

April 6, 2001